Mental health promotion practice in Aotearoa New Zealand: findings from a qualitative study.

New Zealand health promotion practice mental health mental health promotion qualitative

Journal

Health promotion international
ISSN: 1460-2245
Titre abrégé: Health Promot Int
Pays: England
ID NLM: 9008939

Informations de publication

Date de publication:
01 Oct 2023
Historique:
medline: 1 11 2023
pubmed: 21 10 2023
entrez: 21 10 2023
Statut: ppublish

Résumé

Mental health promotion (MHP) is integral to improving the overall health and well being of individuals, communities, and populations. However, knowledge and reporting about MHP which occurs throughout Aotearoa New Zealand (NZ) is limited. This article reports findings from a qualitative study that sought to understand NZ health promotion practitioners' (HPPs) MHP practice. Semi-structured interviews were undertaken with 15 HPPs employed at various health promotion organizations. Thematic analysis of interview transcripts identified three key themes. Two themes (planning and evaluation) related to practice directly and included various subthemes: needs assessment; principles/approaches/frameworks; operationalizing equity and te Tiriti o Waitangi; collaborative approaches; planning for evaluation; process evaluation domination; and evaluation challenges. The third theme related to the context of practice and encompassed various system influences restricting HPPs from practising as they wished. These were represented in four subthemes: contractual agreements; field fragmentation; in the shadows of mental ill-health and workforce capacity. Study findings highlight several opportunities to improve MHP practice in NZ. Most pertinently, the need for system-level action to address the factors restricting HPPs' practice.

Identifiants

pubmed: 37864800
pii: 7326502
doi: 10.1093/heapro/daad137
pmc: PMC10590158
pii:
doi:

Substances chimiques

N-succinimidyl-3-(4-hydroxyphenyl)propionate 34071-95-9

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Brooke Craik
Organisme : University of Otago

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press.

Références

Glob Health Promot. 2015 Mar;22(1):32-45
pubmed: 24853825
Health Promot Pract. 2015 Sep;16(5):715-23
pubmed: 25690614
N Z Med J. 2017 Nov 10;130(1465):96-103
pubmed: 29121628
Prev Med. 2016 Jun;87:70-80
pubmed: 26896634
Curr Opin Psychiatry. 2017 Sep;30(5):339-345
pubmed: 28661906
Health Promot J Austr. 2020 Sep;31(3):456-467
pubmed: 31408247
Soc Sci Med. 2014 Apr;106:214-20
pubmed: 24583568
Ethn Health. 2017 Apr;22(2):105-118
pubmed: 27323889
Qual Health Res. 2016 Nov;26(13):1753-1760
pubmed: 26613970
Soc Sci Med. 2018 Feb;199:132-139
pubmed: 28602358
BMC Public Health. 2013 Sep 11;13:835
pubmed: 24025155
Aust N Z J Psychiatry. 2019 Nov;53(11):1116-1117
pubmed: 31672046
BMC Public Health. 2022 Feb 1;22(1):210
pubmed: 35100999
Health Promot Int. 2020 Feb 1;35(1):111-122
pubmed: 30601952
BMC Psychol. 2018 Jul 05;6(1):30
pubmed: 29976252
Health Promot Int. 2006 Dec;21 Suppl 1:36-41
pubmed: 17307955
N Z Med J. 2004 Aug 06;117(1199):U997
pubmed: 15475980
N Z Med J. 2004 Aug 06;117(1199):U998
pubmed: 15475981
Promot Educ. 2007;Suppl 2:23-7
pubmed: 17685076
J Bioeth Inq. 2021 Mar;18(1):59-70
pubmed: 33428152
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Am J Mens Health. 2017 Nov;11(6):1823-1837
pubmed: 28884637
Health Promot Int. 2022 Feb 17;37(1):
pubmed: 34189584
Health Promot Int. 2011 Dec;26 Suppl 2:ii216-25
pubmed: 22080076
Soc Sci Med. 1985;20(5):483-6
pubmed: 3992288
J Adv Nurs. 2001 Jan;33(2):250-6
pubmed: 11168709
Health Promot Int. 2014 Sep;29(3):463-73
pubmed: 23445941
Eval Program Plann. 2017 Apr;61:38-44
pubmed: 27915114
Aust N Z J Psychiatry. 2014 Apr;48(4):360-70
pubmed: 24253359
Aust N Z J Psychiatry. 2006 Oct;40(10):905-13
pubmed: 16959017
Nurs Ethics. 2002 Nov;9(6):636-50
pubmed: 12450000
Health Promot Int. 2011 Jun;26(2):244-54
pubmed: 20739324

Auteurs

Brooke Craik (B)

Ngāi Tahu Māori Health Research Unit, Division of Health Sciences, University of Otago, Dunedin, Aotearoa, New Zealand.

Richard Egan (R)

Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago, Dunedin, Aotearoa, New Zealand.

Francis Kewene (F)

Te Herenga Waka, Victoria University of Wellington, School of Health, Wellington, Aotearoa, New Zealand.

Kate C Morgaine (KC)

Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago, Dunedin, Aotearoa, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH